610

PROSPECTIVE EVALUATION OF SURGICAL TECHNIQUES FOR SUBTOTAL CHOLECYSTECTOMY IN PATIENTS WITH ACUTE CHOLECYSTITIS: AN EAST MULTICENTER STUDY

Date
May 19, 2024

Background: Different techniques have been described for performance of subtotal cholecystectomy, namely fenestrating and reconstituting subtypes. Currently, little remains known about the impact of these different techniques on short-term and long-term patient outcomes. The aim of this study is to compare various clinical outcomes between patients undergoing fenestrated and reconstituting subtotal cholecystectomy for acute cholecystitis.
Methods: This is a multicenter prospective observational study sponsored by the EAST Multicenter Trials Committee. Between July 2019 and June 2022, we included patients (age ≥18 years) who received surgical management of acute cholecystitis defined by the Tokyo Guideline 18 diagnostic criteria. In-hospital and long-term (6-month) outcomes for patients undergoing fenestrating versus reconstituting subtotal cholecystectomy were compared.
Results: A total of 2,685 patients with acute cholecystitis were enrolled from 9 centers. The median age was 41 years (IQR: 30-53) and 28% were male. Diabetes mellitus was the most common comorbid condition (12%). Of those, 162 patients (6.1%) underwent subtotal cholecystectomy (laparoscopic: 128 (79%), laparoscopic converted to open: 30, open: 4), whereas laparoscopic converted to open total cholecystectomy was performed in 41 patients (1.6%). Approximately 78% of subtotal cholecystectomy used fenestrating technique rather than reconstituting technique (Table 1). In the early postoperative period, patients in the fenestrating group more commonly developed bile leaks (32% versus 8.6%, p=0.005) and required readmission within 30 days (30/125: 24% versus 2/35: 5.7%, p=0.016). There were not significant differences in the rate of secondary interventions (34% versus 17%, p=0.063). At 6-month follow-up, the incidence of recurrent biliary disease was statistically similar between the fenestrating and reconstituting groups (11% versus 21%, p=0.158). Only 5 patients (4.3%) underwent completion cholecystectomy during the follow-up period.
Conclusions: In this multicenter study, subtotal cholecystectomy was more commonly performed than open conversion total cholecystectomy as a bail-out procedure for acute cholecystitis. Both fenestrating and reconstituting subtypes were associated with recurrent biliary disease and complications requiring secondary intervention and readmission in the early and later postoperative period.

Tracks

Related Products

Thumbnail for ROBOTIC TRANSGASTRIC PANCREATIC NECROSECTOMY: SINGLE STAGE PROCEDURE FOR WALLED-OFF PANCREATIC NECROSIS
ROBOTIC TRANSGASTRIC PANCREATIC NECROSECTOMY: SINGLE STAGE PROCEDURE FOR WALLED-OFF PANCREATIC NECROSIS
45 yo M with walled off pancreatic necrosis who underwent robotic cystogastrostomy and transgastric pancratic necrosectomy. CT scan demonstrated necrosis confined to the lesser sac. A step-up approach was unsuccessful. Robotic debridement was offered…
Thumbnail for ROBOTIC ANATOMICAL RIGHT HEPATECTOMY FOR NECROTIC CHOLANGIOCARCINOMA
TECHNIQUE OF INFLOW CONTROL IN NAKAMURA TYPE B PORTAL VEIN ANATOMY
ROBOTIC ANATOMICAL RIGHT HEPATECTOMY FOR NECROTIC CHOLANGIOCARCINOMA TECHNIQUE OF INFLOW CONTROL IN NAKAMURA TYPE B PORTAL VEIN ANATOMY
Anatomical variations in the inflow vasculatures must be anticipated in any anatomical hepatectomy to avoid complications. Nakamura Type B portal vein (PV) anatomy requires individual isolation of right anterior and posterior PV to avoid narrowing of the left PV…
Thumbnail for ROBOTIC PANCREATICODUODENECTOMY (PD) FOR OBSTRUCTING AMPULLARY MASS
ROBOTIC PANCREATICODUODENECTOMY (PD) FOR OBSTRUCTING AMPULLARY MASS
This video depicts a robotic PD performed on a 69-year-old male presenting with flu-like
Thumbnail for LAPAROSCOPIC TOTAL PANCREATECTOMY AFTER LAPAROSCOPIC WHIPPLE FOR PANCREATIC DUCTAL ADENOCARCINOMA
LAPAROSCOPIC TOTAL PANCREATECTOMY AFTER LAPAROSCOPIC WHIPPLE FOR PANCREATIC DUCTAL ADENOCARCINOMA
Improvements in systemic therapy may increase rate of 2nd novo PDAC after prior PDAC